Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

China Maple Leaf Educational Systems Limited Board/Management Information 2017

Aug 27, 2017

49847_rns_2017-08-27_d9e442ba-a3d1-412a-8985-d100fac16882.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [78 x 68] intentionally omitted <==

China Maple Leaf Educational Systems Limited 中國楓葉教育集團有限公司[*]

(Incorporated in the Cayman Islands with limited liability)

(Stock code: 1317)

CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTOR, CHANGE OF THE COMPOSITION OF AUDIT COMMITTEE, REMUNERATION COMMITTEE AND NOMINATION AND CORPORATE GOVERNANCE COMMITTEE

RESIGNATION OF DIRECTOR

The board (the “ Board ”) of directors (“ Directors ”) of China Maple Leaf Educational Systems Limited (the “ Company ”) announces that due to personal reasons, Mr. Chak Kei Jack Wong (“ Mr. Wong ”) has tendered his resignation as independent non-executive Director and from memberships from all committees of the Company with effect from 27 August 2017.

Mr. Wong confirms that he does not have any disagreement with the Board and that there is no other matter relating to his resignation which need to be brought to the attention of the shareholders of the Company.

The Board would like to express its sincere gratitude to Mr. Wong for his invaluable contribution to the Board during their term of office with the Company.

APPOINTMENT OF DIRECTOR

The Board is pleased to announce that Dr. Xiaodan Mei (“ Dr. Mei ”) has been appointed as an independent non-executive Director of the Company and a member of the audit committee, remuneration committee and nomination and corporate governance committee with effect from 27 August 2017.

Set out below are the biographical details of Dr. Mei:

Dr. Mei, aged 53, is the founder and president of BIT Congress Inc., a PRC company founded in 2003 and headquartered in Dalian which is principally engaged in the provision of conference organising and event management services. Prior to the founding of BIT Congress Inc., Dr. Mei was employed as a scientist at Proscript, which founded by Professor Dr. Tom Maniatis at Harvard University. From 1997 to 2000, he was employed as a scientist at Biogen-Idec and the Senior Scientist at Anadys.

1

Dr. Mei completed his bachelor degree in China Pharmaceutical University majoring in pharmaceutical chemistry in 1984. Dr. Mei received his master degree from Shanghai Institute of Pharmaceutical Industry in 1989. In 1996, Dr. Mei obtained his Ph.D. degree in Biochemistry and Organic Chemistry from the Department of Chemistry and Biochemistry at the University of Oklahoma.

Dr. Mei will sign an appointment letter with the Company for a period from 27 August 2017 to 31 August 2019, subject to re-election and retirement as required by the articles of association of the Company. Dr. Mei is entitled to receive a director’s fee of HK$360,000 per annum as determined by the Board with reference to the experience, responsibility, workload, time devoted, emoluments paid by comparable companies and performance of the Company.

As at the date of this announcement, Dr. Mei is not interested in any shares of the Company within the meaning of Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).

Save as disclosed above, Dr. Mei is independent from and has no relationship with any Director, senior management, substantial shareholder or controlling shareholder of the Company, nor has he held any directorship in any other listed public companies in the past three years or any other position with the Company or any of its subsidiaries.

Save as disclosed above, there is no information which is discloseable nor is Dr. Mei involved in any of the matters required to be disclosed pursuant to any of the requirements under Rules 13.51(2)(h) to 13.51(2)(v) of the Rules Governing the Listing of Securities of The Stock Exchange of Hong Kong Limited and there are no other matters concerning Dr. Mei that need to be brought to the attention of the shareholders of the Company.

The Board would like to take this opportunity to welcome Dr. Mei on his new appointment.

By order of the Board China Maple Leaf Educational Systems Limited Shu Liang Sherman Jen Chairman and Chief Executive Officer

Hong Kong, 27 August 2017

As at the date of this announcement, the Board comprises Mr. Shu Liang Sherman Jen, Ms. Jingxia Zhang and Mr. James William Beeke as executive Directors; Mr. Howard Robert Balloch as non-executive Director; and Mr. Peter Humphrey Owen, Dr. Xiaodan Mei and Mr. Lap Tat Arthur Wong as independent non-executive Directors.

  • For identification purposes only

2